Moreover, it should be noted that while all patients with pneumonia showed detectable or borderline proliferative CD4+ T-cell response at both time points, 3/11 (27%) mild COVID-19 patients and 2/20 (10%) vaccinated subjects did not show a detectable response at the early time points. The gene discussed is CD4; the disease is susceptibility to pneumonia measurement.